Ole Andreas Halvorsen
Viking Global Investors
Ole Andreas Halvorsen Acadia Healthcare Company Inc stake
total: 670
Viking Global Investors ACHC trades
- Total transactions:
- 19
- New positions:
- 2
- Sold out:
- 2
- Added:
- 10
- Reduced:
- 5
- Held since:
- 2020 Q4
- Held for:
- 16 quarters
- Latest activity:
- 2024 Q4
According to 2026 Q2 report, Ole Andreas Halvorsen doesn't hold any Acadia Healthcare Company Inc (ACHC) shares. To date, the estimated cost basis is nearly $65.02 for "buy" trades and estimated average "sell" price is $67. Viking Global Investors first purchased ACHC in 2017 Q1, initially acquiring 755,830 shares. Ole Andreas Halvorsen later completely sold out the position and invested in Acadia Healthcare Company Inc again in 2020 Q4. Since the initial investment in Acadia Healthcare Company Inc (ACHC), Viking Global Investors has made 18 more transactions.
When did Ole Andreas Halvorsen sell Acadia Healthcare Company Inc (ACHC)?
Ole Andreas Halvorsen sold off the entire Acadia Healthcare Company Inc (ACHC) position in 2024 Q4.
When did Ole Andreas Halvorsen buy Acadia Healthcare Company Inc (ACHC)?
Ole Andreas Halvorsen first invested in Acadia Healthcare Company Inc (ACHC) in 2017 Q1 at the reported quarter-end price of $43.60 per share.
What's the cost basis of Viking Global Investors's ACHC stake?
The estimated cost basis for Acadia Healthcare Company Inc (ACHC) stake is around $65.02 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $65.02
- Weighted AVG sell price:
- $67.00
Ole Andreas Halvorsen's historical trades in Acadia Healthcare Company Inc
19 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2024 Q4
|
0.00%
|
0
|
$63.41
|
|
-100% (-3,701,347)
|
-0.86%
|
|
2024 Q3
|
0.86%
|
3,701,347
|
$63.41
|
$234,702,413
|
+14.35% (+464,562)
|
+0.11%
|
|
2024 Q2
|
0.84%
|
3,236,785
|
$67.54
|
$218,612,459
|
+26.23% (+672,548)
|
+0.17%
|
|
2024 Q1
|
0.76%
|
2,564,237
|
$79.22
|
$203,138,855
|
-8.43% (-236,113)
|
-0.07%
|
|
2023 Q4
|
0.80%
|
2,800,350
|
$77.76
|
$217,755,216
|
+24.17% (+545,137)
|
+0.16%
|
|
2023 Q3
|
0.64%
|
2,255,213
|
$70.31
|
$158,564,026
|
-30.41% (-985,681)
|
-0.28%
|
|
2023 Q2
|
1.06%
|
3,240,894
|
$79.64
|
$258,104,798
|
-3.38% (-113,216)
|
-0.04%
|
|
2023 Q1
|
1.14%
|
3,354,110
|
$72.25
|
$242,334,448
|
+6.11% (+192,996)
|
+0.07%
|
|
2022 Q4
|
1.30%
|
3,161,114
|
$82.32
|
$260,222,904
|
+6.83% (+202,182)
|
+0.08%
|
|
2022 Q3
|
1.07%
|
2,958,932
|
$78.18
|
$231,329,000
|
-14.94% (-519,544)
|
-0.19%
|
|
2022 Q2
|
1.08%
|
$67.63
|
+63.28% (+1,348,043)
|
|||
|
2022 Q1
|
0.56%
|
$65.53
|
+1.91% (+39,857)
|
|||
|
2021 Q4
|
0.37%
|
$60.70
|
-0.58% (-12,182)
|
|||
|
2021 Q3
|
0.37%
|
$63.78
|
+2.07% (+42,633)
|
|||
|
2021 Q2
|
0.39%
|
$62.75
|
+24.71% (+408,135)
|
|||
|
2021 Q1
|
0.28%
|
$57.14
|
+383.32% (+1,310,191)
|
|||
|
2020 Q4
|
0.05%
|
$50.26
|
new
|
|||
|
2017 Q2
|
0.00%
|
$43.60
|
-100% (-755,830)
|
|||
|
2017 Q1
|
0.15%
|
$43.60
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.